Drug Approval | December 27, 2021
Covaxin receives approval for Emergency Use in Children 12-18 years
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
The Home Healthcare market is expected to be US $ 14.2 by 2025
Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000
He has over 22 years of experience in pharmaceutical sales & business development
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
The company has started manufacturing the Sputnik Light vaccine
The VaxIT app, developed on the Salesforce platform for Azim Premji Foundation and its partners, captures the status of vaccinations to help individuals plan and stay updated on their progress
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
2022 is going to be the year of opportunities and innovations from the medical industry in India
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
Subscribe To Our Newsletter & Stay Updated
